$RGEN
REPLIGEN CORP Stock $rgen

$rgen Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000119312516758650 Filed on November 03, 2016

Income Statement

Concept	2016 Q3	2015 Q3
Revenue	$24.68M	$19.81M
YoY Change	24.54%	29.69%
Cost Of Revenue	$11.24M	$8.444M
YoY Change	33.14%	21.83%
Gross Profit	$13.44M	$11.37M
YoY Change	18.16%	36.22%
Gross Profit Margin	54.44%	57.38%
Selling, General & Admin	$7.127M	$5.959M
YoY Change	19.6%	33.28%
% of Gross Profit	53.05%	52.41%
Research & Development	$1.886M	$1.490M
YoY Change	26.58%	-9.7%
% of Gross Profit	14.04%	13.1%
Depreciation & Amortization	$1.370M	$1.150M
YoY Change	19.13%	4.55%
% of Gross Profit	10.2%	10.11%
Operating Expenses	$9.013M	$7.449M
YoY Change	21.0%	21.7%
Operating Profit	$3.747M	$3.688M
YoY Change	1.6%	66.43%
Interest Expense	$1.555M	$8.000K
YoY Change	19337.5%	-27.27%
% of Operating Profit	41.5%	0.22%
Other Income/Expense, Net	-$75.00K	-$38.00K
YoY Change	97.37%	171.43%
Pretax Income	$2.214M	$3.679M
YoY Change	-39.82%	63.15%
Income Tax	$1.059M	$1.141M
% Of Pretax Income	47.83%	31.01%
Net Earnings	$1.155M	$2.538M
YoY Change	-54.49%	73.12%
Net Earnings / Revenue	4.68%	12.81%
Basic Earnings Per Share	$0.03	$0.08
Diluted Earnings Per Share	$0.03	$0.08
COMMON SHARES
Basic Shares Outstanding	33.78M shares	32.93M shares
Diluted Shares Outstanding	34.31M shares	33.69M shares

Balance Sheet

Concept	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$178.7M	$68.90M
YoY Change	159.36%	27.36%
Cash & Equivalents	$157.7M	$48.08M
Short-Term Investments	$21.10M	$20.80M
Other Short-Term Assets	$1.300M	$1.100M
YoY Change	18.18%	-8.33%
Inventory	$24.46M	$15.90M
Prepaid Expenses
Receivables	$15.15M	$10.32M
Other Receivables	$200.0K	$100.0K
Total Short-Term Assets	$219.8M	$96.28M
YoY Change	128.33%	27.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.94M	$13.97M
YoY Change	6.88%	5.93%
Goodwill	$31.16M	$14.35M
YoY Change	117.21%	1.43%
Intangibles	$18.67M	$13.15M
YoY Change	41.94%	-14.3%
Long-Term Investments	$0.00	$1.700M
YoY Change	-100.0%	-83.0%
Other Assets	$500.0K	$500.0K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$65.22M	$43.57M
YoY Change	49.67%	-18.0%
TOTAL ASSETS
Total Short-Term Assets	$219.8M	$96.28M
Total Long-Term Assets	$65.22M	$43.57M
Total Assets	$285.1M	$139.9M
YoY Change	103.82%	8.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.061M	$2.951M
YoY Change	71.5%	6.81%
Accrued Expenses	$15.13M	$12.76M
YoY Change	18.6%	65.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.19M	$15.71M
YoY Change	28.54%	50.03%
LONG-TERM LIABILITIES
Long-Term Debt	$94.30M	$0.00
YoY Change
Other Long-Term Liabilities	$1.894M	$2.693M
YoY Change	-29.67%	-26.97%
Total Long-Term Liabilities	$1.894M	$2.693M
YoY Change	-29.67%	-26.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.19M	$15.71M
Total Long-Term Liabilities	$1.894M	$2.693M
Total Liabilities	$22.09M	$18.40M
YoY Change	20.02%	29.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$64.89M	-$71.81M
YoY Change	-9.63%	-10.79%
Common Stock	$240.9M	$202.0M
YoY Change	19.27%	61663.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$166.5M	$121.5M
YoY Change
Total Liabilities & Shareholders Equity	$285.1M	$139.9M
YoY Change	103.82%	8.55%

Cashflow Statement

Concept	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	$1.155M	$2.538M
YoY Change	-54.49%	73.12%
Depreciation, Depletion And Amortization	$1.370M	$1.150M
YoY Change	19.13%	4.55%
Cash From Operating Activities	-$1.180M	$6.590M
YoY Change	-117.91%	4.11%
INVESTING ACTIVITIES
Capital Expenditures	-$2.050M	-$320.0K
YoY Change	540.62%	-81.61%
Acquisitions
YoY Change
Other Investing Activities	-$11.85M	$1.930M
YoY Change	-713.99%	9550.0%
Cash From Investing Activities	-$13.90M	$1.620M
YoY Change	-958.02%	-194.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	420.0K	240.0K
YoY Change	75.0%	-152.17%
NET CHANGE
Cash From Operating Activities	-1.180M	6.590M
Cash From Investing Activities	-13.90M	1.620M
Cash From Financing Activities	420.0K	240.0K
Net Change In Cash	-14.66M	8.450M
YoY Change	-273.49%	103.61%
FREE CASH FLOW
Cash From Operating Activities	-$1.180M	$6.590M
Capital Expenditures	-$2.050M	-$320.0K
Free Cash Flow	$870.0K	$6.910M
YoY Change	-87.41%	-14.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1252356	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.47
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48084000
CY2016Q3	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	3	Investment
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	12.26
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33822962	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1929834	shares
CY2016Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	683148	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1115150	shares
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33822962	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	432002	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.28
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1198673	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.03
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q3	us-gaap	Share Price SharePrice	30.19
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64891000
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1894000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2410000
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	285050000
CY2016Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	476000
CY2016Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4440000
CY2016Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	643000
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9496000
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5061000
CY2016Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	429000
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	166522000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	622000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2410000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2410000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2410000
CY2016Q3	us-gaap	Interest Payable Current InterestPayableCurrent	862000
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	338000
CY2016Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	240571000
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18994000
CY2016Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	357000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2410000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6309000
CY2016Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2124000
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19000
CY2016Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	749000
CY2016Q3	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	0
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	798000
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	20192000
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6261000
CY2016Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	94318000
CY2016Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	6261000
CY2016Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	592000
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15131000
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	1000
CY2016Q3	us-gaap	Assets Current AssetsCurrent	219833000
CY2016Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2126000
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14935000
CY2016Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	450000
CY2016Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	8396000
CY2016Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	21060000
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	1415000
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	157651000
CY2016Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	9276000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1999000
CY2016Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18671000
CY2016Q3	us-gaap	Inventory Net InventoryNet	24463000
CY2016Q3	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	0
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	20396000
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15154000
CY2016Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1382000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	553000
CY2016Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3353000
CY2016Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	14750000
CY2016Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	226000
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33929000
CY2016Q3	us-gaap	Assets Assets	285050000
CY2016Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1358000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1666000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2022000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2211000
CY2016Q3	us-gaap	Goodwill Goodwill	31161000
CY2016Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	24980000
CY2016Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	15569000
CY2016Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6768000
CY2016Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	14444000
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1279000
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22172000
CY2016Q3	rgen	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	1672000
CY2016Q3	rgen	Impact Of Credit Risk On Fair Value Of Derivatives ImpactOfCreditRiskOnFairValueOfDerivatives	0
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33831867	shares
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35363000
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32949353	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32949353	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1240935	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.44
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71542000
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4257000
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	146237000
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	343000
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4680000
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	258000
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8566000
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6724000
CY2015Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	604000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	122748000
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	329000
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	202527000
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16496000
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	269000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4885000
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	451000
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	31000
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	166000
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1593000
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18781000
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6788000
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4480000
CY2015Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	7000
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	7000
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12057000
CY2015Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	18000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	103252000
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1586000
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13801000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	450000
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	17682000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54092000
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12755000
CY2015Q4	us-gaap	Inventory Net InventoryNet	17998000
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11300000
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	19326000
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	425000
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2808000
CY2015Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	13758000
CY2015Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	82000
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30297000
CY2015Q4	us-gaap	Assets Assets	146237000
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	19315000
CY2015Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1633000
CY2015Q4	us-gaap	Goodwill Goodwill	14346000
CY2015Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	17640000
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	10671000
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5741000
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	13306000
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2098000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	170891	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	11701000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33617999	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32860382	shares
	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.41
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	757617	shares
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.258	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1862000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2055000
	us-gaap	Investment Income Net InvestmentIncomeNet	92000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	62088000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14090000
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	99000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	43000
	us-gaap	Operating Income Loss OperatingIncomeLoss	12336000
	us-gaap	Net Income Loss NetIncomeLoss	9080000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4051000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2756000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6125000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2998000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2671000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-175000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-183000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-699000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12229000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2114000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	218000
	us-gaap	Depreciation Depreciation	2251000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1927000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3149000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-749000
	us-gaap	Interest Expense InterestExpense	24000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	2119000
	us-gaap	Share Based Compensation ShareBasedCompensation	2668000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3449000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18226000
	us-gaap	Costs And Expenses CostsAndExpenses	49752000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1085000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	828000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4309000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1201000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	12721000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	25103000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	927000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	18264000
	rgen	Increase Decrease In Noncurrent Liabilities IncreaseDecreaseInNoncurrentLiabilities	-240000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	348608	shares
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Type DocumentType	10-Q
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
	dei	Entity Central Index Key EntityCentralIndexKey	0000730272
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5567000
	dei	Trading Symbol TradingSymbol	RGEN
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34011534	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33485448	shares
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	102730	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y5M27D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.81
	us-gaap	Basis Of Accounting BasisOfAccounting	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <b>1. Basis of Presentation</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The consolidated financial statements included herein have been prepared by Repligen Corporation (the “Company,” “Repligen” or “we”) in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for Quarterly Reports on <font style="WHITE-SPACE: nowrap">Form 10-Q</font> and Article 10 of <font style="WHITE-SPACE: nowrap">Regulation S-X</font> and do not include all of the information and footnote disclosures required by U.S. GAAP. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on <font style="WHITE-SPACE: nowrap">Form 10-K</font> for the fiscal year ended December 31, 2015.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Repligen Sweden AB (“Repligen Sweden”), Repligen GmbH (acquired as Atoll GmbH as of April 1, 2016 and renamed on September 20, 2016) and Repligen Singapore Pte. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Recently Issued Accounting Pronouncements</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) <font style="WHITE-SPACE: nowrap">No. 2015-03,</font> “Interest – Imputation of Interest (Topic 835): Simplifying the Presentation of Debt Issuance Costs.” <font style="WHITE-SPACE: nowrap">ASU 2015-03</font> requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The ASU became effective for public entities for fiscal years beginning after December 15, 2015. The Company applied the amended presentation requirements in conjunction with its issuance of convertible senior notes in the second quarter of 2016.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In May 2014, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No. 2014-09,</font> “Revenue from Contracts with Customers (Topic 606),” which supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, <i>Revenue Recognition</i>, and creates a new Topic 606, <i>Revenue from Contracts with Customers</i>. Two adoption methods are permitted: retrospectively to all prior reporting periods presented, with certain practical expedients permitted; or retrospectively with the cumulative effect of initially adopting the ASU recognized at the date of initial application. The adoption of this ASU will include updates as provided under <font style="WHITE-SPACE: nowrap">ASU 2015-14,</font> “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date”; <font style="WHITE-SPACE: nowrap">ASU 2016-08,</font> “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)”; <font style="WHITE-SPACE: nowrap">ASU 2016-10,</font> “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing”; and <font style="WHITE-SPACE: nowrap">ASU 2016-12,</font> “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.” The Company has not yet determined which adoption method it will utilize or the effect that the adoption of this guidance will have on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In July 2015, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No. 2015-11,</font> “Inventory (Topic 330): Simplifying the Measurement of Inventory” <font style="WHITE-SPACE: nowrap">(“ASU 2015-11”).</font> <font style="WHITE-SPACE: nowrap">ASU 2015-11</font> requires inventory be measured at the lower of cost and net realizable value, and options that currently exist for market value be eliminated. <font style="WHITE-SPACE: nowrap">ASU 2015-11</font> defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective prospectively for reporting periods beginning after December 15, 2016 and interim periods within those fiscal years with early adoption permitted. The Company does not expect the adoption of <font style="WHITE-SPACE: nowrap">ASU 2015-11</font> to have a material impact on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In February 2016, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No. 2016-02,</font> “Leases (Topic 842)” <font style="WHITE-SPACE: nowrap">(“ASU 2016-02”).</font> <font style="WHITE-SPACE: nowrap">ASU 2016-02</font> requires lessees to recognize a right-of-use asset and a lease liability for most leases. Extensive quantitative and qualitative disclosures, including significant judgments made by management, will be required to provide greater insight into the extent of revenue and expense recognized and expected to be recognized from existing contracts. The accounting applied by a lessor is largely unchanged from that applied under the current standard. The standard must be adopted using a modified retrospective transition approach and provides for certain practical expedients. The ASU is effective for public entities for fiscal years beginning after December 15, 2018, with early adoption permitted. The Company has not yet completed its assessment of the impact of the new standard on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">  </p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> In March 2016, the FASB issued ASU No. 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”, which aims to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, classification of certain items on the statement of cash flows and accounting for forfeitures. The ASU is effective for public entities for fiscal years beginning after December 15, 2016, with early adoption permitted. The Company intends to adopt the provisions of this ASU as of January 1, 2017; the Company does not expect the impact of this new standard to have a material effect on its 2017 consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In August 2016, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No. 2016-15,</font> “Statement of Cash Flows (Topic 203): Classification of Certain Cash Receipts and Cash Payments”. ASU <font style="WHITE-SPACE: nowrap">No. 2016-15</font> addresses eight specific cash flow issues and clarifies their presentation and classification in the Statement of Cash Flows. ASU <font style="WHITE-SPACE: nowrap">No. 2016-15</font> is effective for fiscal years beginning after December 15, 2017 and is to be applied retrospectively with early adoption permitted. The Company currently classifies payments up to the amount of its contingent consideration liability recognized at the date of its acquisition of Refine Technology, LLC (“Refine”) as financing activities, with additional payments classified as operating activities. As a result, the Company does not expect the adoption of <font style="WHITE-SPACE: nowrap">ASU 2016-15</font> to have a material impact on its consolidated financial statements.</p> </div>
	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y5M5D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.80
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.22
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	526086	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	305535	shares
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.343	pure
	dei	Entity Registrant Name EntityRegistrantName	REPLIGEN CORP
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	366003	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y5M1D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2905000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3462000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8767000
	us-gaap	Investment Income Net InvestmentIncomeNet	234000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	15000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	78942000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	21394000
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	498000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	89000
	us-gaap	Operating Income Loss OperatingIncomeLoss	13068000
	us-gaap	Net Income Loss NetIncomeLoss	6651000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6457000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3270000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5721000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1019000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2888000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	928000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3317000
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2115000
	us-gaap	Stock Issued1 StockIssued1	14135000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-979000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-930000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-20000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-820000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10125000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-25000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3317000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	326000
	us-gaap	Depreciation Depreciation	2360000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-332000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3474000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1918000
	us-gaap	Interest Expense InterestExpense	2198000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13878000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	45000
	us-gaap	Share Based Compensation ShareBasedCompensation	3341000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1320000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3844000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	111070000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22286000
	us-gaap	Costs And Expenses CostsAndExpenses	65874000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2389000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	112202000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5316000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1484000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	103559000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	34955000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	4781000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1630000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	19700000
	rgen	Increase Decrease In Noncurrent Liabilities IncreaseDecreaseInNoncurrentLiabilities	-48000
	rgen	Marketable Debt Securities Weighted Average Remaining Maturity Period MarketableDebtSecuritiesWeightedAverageRemainingMaturityPeriod	P6M3D
	rgen	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Foreign Currency Translation Adjustments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignCurrencyTranslationAdjustments	9000
	rgen	Long Term Marketable Securities Maturities Term Minimum LongTermMarketableSecuritiesMaturitiesTermMinimum	P1Y
	rgen	Nonrefundable Upfront Cash Payment Under Collaborations Agreement NonrefundableUpfrontCashPaymentUnderCollaborationsAgreement	2000000
	rgen	Amount To Be Received Upon Completion Of Transfer AmountToBeReceivedUponCompletionOfTransfer	125675
	rgen	Payment Of Contingent Consideration In Common Stock PaymentOfContingentConsiderationInCommonStock	875000
CY2015	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2014Q1	rgen	Non Contingent Consideration Being Recognized As Revenue Over Estimated Period Of Performance NonContingentConsiderationBeingRecognizedAsRevenueOverEstimatedPeriodOfPerformance	2000000
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	163459	shares
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2015Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33689560	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32925004	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	764556	shares
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.310	pure
CY2015Q3	us-gaap	Investment Income Net InvestmentIncomeNet	37000
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	19814000
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	65000
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3688000
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	2538000
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2007000
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-596000
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-38000
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3679000
CY2015Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	233000
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1141000
CY2015Q3	us-gaap	Interest Expense InterestExpense	8000
CY2015Q3	us-gaap	Share Based Compensation ShareBasedCompensation	981000
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5959000
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	16126000
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1490000
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	8444000
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	253754	shares
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34312887	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33779141	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	533746	shares
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.478	pure
CY2016Q3	us-gaap	Investment Income Net InvestmentIncomeNet	97000
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	24677000
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	74000
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3747000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	1155000
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	843000
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-386000
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75000
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2214000
CY2016Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	675000
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1059000
CY2016Q3	us-gaap	Interest Expense InterestExpense	1555000
CY2016Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1282000
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7127000
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	20930000
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1886000
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	11242000

Files In Submission

Name	View Source	Status
0001193125-16-758650-index-headers.html	Edgar Link	pending
0001193125-16-758650-index.html	Edgar Link	pending
0001193125-16-758650.txt	Edgar Link	pending
0001193125-16-758650-xbrl.zip	Edgar Link	pending
d270155d10q.htm	Edgar Link	pending
d270155dex311.htm	Edgar Link	pending
d270155dex312.htm	Edgar Link	pending
d270155dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rgen-20160930.xml	Edgar Link	completed
rgen-20160930.xsd	Edgar Link	pending
rgen-20160930_cal.xml	Edgar Link	unprocessable
rgen-20160930_def.xml	Edgar Link	unprocessable
rgen-20160930_lab.xml	Edgar Link	unprocessable
rgen-20160930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGEN
REPLIGEN CORP Stock $rgen

2016 Q3 Form 10-Q Financial Statement

#000119312516758650 Filed on November 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGEN REPLIGEN CORP Stock $rgen

2016 Q3 Form 10-Q Financial Statement

#000119312516758650 Filed on November 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGEN
REPLIGEN CORP Stock $rgen